The Influence of Cd4+ T Cell Affinity for Self-Antigen on the Development of Inflammatory Arthritis

Loading...
Thumbnail Image
Degree type
Doctor of Philosophy (PhD)
Graduate group
Immunology
Discipline
Subject
anti-TNF and anti-B cell treatments
autoreactive CD4+ T cells
CD4+ T cell affinity
mouse models of autoimmune arthritis
pathways of pathogenesis
Th17 and B cells in autoimmunity
Allergy and Immunology
Immunology and Infectious Disease
Medical Immunology
Funder
Grant number
License
Copyright date
2014-08-22T00:00:00-07:00
Distributor
Related resources
Contributor
Abstract

CD4+ T cells make a crucial contribution to the development of inflammatory arthritis both in humans and in mouse models. However, how the affinity with which T cells recognize target antigens might shape disease development and influence treatment modalities is poorly understood. We have examined these phenomena in mouse models of autoimmune arthritis: TS1xHACII and TS1(SW)xHACII mice express influenza hemagglutinin (HA) as a neo-self peptide and co-express transgenic TCRs that have either high affinity (TS1xHACII) or low affinity (TS1(SW)xHACII) for the HA-derived MHCII determinant, S1. Despite extensive deletion of T cells bearing autoreactive TCRs, arthritis spontaneously develops in both strains. In TS1xHACII mice, males and females develop arthritis equally. CD4+ T cells in this setting display high reactivity to the S1 self-antigen and disease is accompanied by high levels of pro-inflammatory cytokines. Arthritis was found to develop by a B cell-independent mechanism in TS1xHACII mice, although it can be suppressed by anti-IL-17 and anti-TNF treatments, the latter which prevented the accumulation of effector CD4+IL-17+ cells in the joints of treated mice. By contrast, arthritis develops with a significant female bias in the context of a more weakly autoreactive CD4+ T cell response in TS1(SW)xHACII mice and disease was accompanied by lower levels of inflammatory cytokines. IL-17 is also required for disease development in this setting as well; B cells, in this case however, were found to play a prominent role in disease pathogenesis. Rather than acting as a source of arthritogenic autoantibodies, B cells appear to serve as APCs to promote the formation of autoreactive CD4+ effector T cells (including Th17 cells). Unlike in TS1xHACII mice, anti-TNF treatment appears to modulate disease severity but was insufficient to ameliorate the onset of disease in TS1(SW)xHACII mice. These studies demonstrate that variations in the CD4+ T cell response to a single target autoantigen can play a prominent role in guiding the pathways to inflammatory arthritis development. These studies may also explain why treatment modalities targeting particular pathways (cytokines vs B cells) can exhibit different efficacies in arthritis patients.

Advisor
Andrew J. Caton
Date of degree
2013-01-01
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation